Navigation auf


Epidemiology, Biostatistics and Prevention Institute

Successful start of the HOMEX-1 trial

We are happy to announce that almost one-third of the required 120 patients
with chronic obstructive pulmonary disease (COPD) have already been successfully recruited for the HOMEX-1 trial in the participating rehabilitation centers Klinik Barmelweid, Berner Reha Zentrum Heiligenschwendi, Zürcher RehaZentren
Wald and Kantonsspital Winterthur. The HOMEX-1 trial, led by EBPI senior researcher Dr. Anja Frei, together with her colleagues Dr. Thomas Radtke and Kaba Dalla Lana, is a two-years, multi-center randomized controlled trial to examine the long-term effects of a post rehabilitation home-based, minimal-equipment exercise training program for persons with COPD, funded by the Research Fund of the Swiss
Lung Association. We thank the involved persons in the rehabilitation centers
for their enthusiastic collaboration in this project.